Cover Image
市場調查報告書

離子通道調製器的全球市場

Ion Channel Modulators

出版商 Global Industry Analysts, Inc. 商品編碼 269629
出版日期 內容資訊 英文 151 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
離子通道調製器的全球市場 Ion Channel Modulators
出版日期: 2018年01月01日 內容資訊: 英文 151 Pages
簡介

本報告提供全球離子通道調製器市場相關調查,彙整市場概要和競爭趨勢,產品概要,各地區的趨勢,及加入此市場的主要企業的簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 預測
    • 離子通道調製器:衰退的市場
    • 現在及未來分析
    • 高齡化
    • 競爭模式
    • 專利失效
  • 產業概要
    • 離子通道:類型,功能的使用,多樣性
    • 現在可取得的離子通道調製器藥物
    • 各作用機制藥物
    • 各治療適應症上的離子通道調製器
    • 離子通道調製器的外包受到高度關注
    • 對亞型的選擇性 其他
  • 產品概要
    • 離子通道調製器:簡介
    • 離子通道的生物學重要性
    • 疾病治療選項的離子通道調製器
    • 離子通道的種類 其他
  • 近幾年的產業活動
  • 主要企業
    • Allergan plc
    • AstraZeneca
    • Bayer HealthCare Pharmaceuticals
    • Biogen, Inc.
    • GlaxoSmithKline Plc.
    • H. Lundbeck A/S
    • Johnson & Johnson
    • Novartis AG
    • Parion Sciences, Inc.
    • Pfizer, Inc.
    • Sanofi S.A.
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 其他各國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6940

This report analyzes the worldwide markets for Ion Channel Modulators in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 39 companies including many key and niche players such as -

Allergan plc
AstraZeneca
Bayer HealthCare Pharmaceuticals
Biogen, Inc.
GlaxoSmithKline Plc
H. Lundbeck A/S

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. OUTLOOK

  • Ion Channel Modulators - A Receding Market
  • Current and Future Analysis
  • Aging Population: Creating Need for More Efficient and Safe Drugs
    • Table 1: Global Population Worldwide: Percentage Share Breakdown by Age Group for the year 2025 (includes corresponding Graph/Chart)
    • Table 2: Global Population of People Aged 65+ Years (In Million) for the Years 2012, 2020 & 2050 (includes corresponding Graph/Chart)
  • Competitive Scenario
    • Table 3: Leading Ion Channel Modulators Worldwide: 2016 (Percentage Breakdown of Revenues) (includes corresponding Graph/Chart)
  • Patent Expiries of Select Ion Channel Modulators

2. INDUSTRY OVERVIEW

  • Ion Channels - A Peek into Their Types, Functional Use and Diversity
  • Ion Channels - Difficult Drug Targets
  • Currently Available Ion Channel Modulating Drugs in the Market
  • Select Ion Channel Modulator Drugs by Mode of Action
  • Ion Channel Modulators by Therapeutic Indication
  • Cardiovascular Diseases/ Hypertension
    • Table 4: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart)
    • Table 5: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart)
    • Table 6: Fatalities in Low Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
    • Table 7: Fatalities in Mid Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
    • Table 8: Fatalities in High Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD, Cancer, Injury, and Others (includes corresponding Graph/Chart)
  • Arrhythmia Treatment
  • Convulsions
  • Pain Management
  • Oncology
  • Diabetes
  • Ion Channel Modulation of Antiemetics
  • Ion Channel Modulators Find Extensive Use in Neglected Tropical Diseases
  • Other Therapeutic Areas
  • Ion Channel Screening Aided by APC
  • Growing Interest in Outsourcing of Ion Channel Services
  • Selectivity against Subtypes - Need of the Hour for Na Channel Blockers
  • Select First Gen Sodium Ion Channel Modulators and Indications
  • Sodium Channel Subtypes, Specific Tissues and Indications
  • Strong Potential Na Channel Blockers for Use in Neuropathic Pain
  • New Trial Questions Nifedipine's Use for Treating Chronic Chilblains

3. PRODUCT OVERVIEW

  • Ion Channel Modulators: An Introduction
  • Biological Significance of Ion Channels
  • Ion Channel Modulators as an Option for Treating Diseases
  • Types of Ion Channels
  • Voltage-Gated Ion Channels
  • Extracellular Ligand-gated Ion Channels
  • Intracellular Ligand-gated Ion Channels

4. RECENT INDUSTRY ACTIVITY

  • Xenon Pharmaceuticals Begins Phase I Trials on XEN1101 Potassium Channel Opener
  • AstraZeneca Inks Agreement with Aspen for Residual Rights to its Anesthetics Portfolio
  • Parion Grants Global Rights for P-321 to Shire
  • Xenon Adds XEN1101 Potassium Channel Modulator to Its Pipeline
  • Alvogen Recalls 24 Lots of Nifedipine
  • Parion Commences Phase II Clinical Trial of P-321
  • AstraZeneca Sells Rights of Anesthetics to Aspen
  • AstraZeneca Inks Licensing Deal with CMS
  • Evotec and Asahi Collaborate for Screening of Ion Channel Targets
  • Catalyst Merges with Targacept
  • XRpro Acquires Pfizer's Ion Channel Biology Platform
  • Vertex and Parion Team Up to Develop ENaC Inhibitors
  • Parion Initiates Enrollment for Phase II Clinical Trial for P-1037 in Cystic Fibrosis
  • Biogen Idec Changes Name to Biogen
  • Biogen Idec Acquires Convergence Pharmaceuticals
  • Pfizer Wins Court Ruling to Block Generic Versions of Lyrica Upto 2018
  • Forest Labs Discontinues Namenda 5/10 mg Tablets, Launches Namenda XR
  • Forest Files Lawsuit against Namenda Generic Manufacturers
  • Cytocentrics Bioscience Selects Drug Safety Testing Center as its Distributor in Japanese Market
  • Zalicus Licenses Its Entire Sodium Channel Modulator Program to AnaBios Corporation
  • EPIRUS Merges with Zalicus

5. FOCUS ON SELECT GLOBAL PLAYERS

  • Allergan plc (Ireland)
  • AstraZeneca (UK)
  • Bayer HealthCare Pharmaceuticals (Germany)
  • Biogen, Inc. (USA)
  • GlaxoSmithKline Plc. (UK)
  • H. Lundbeck A/S (Denmark)
  • Johnson & Johnson (USA)
  • Novartis AG (Switzerland)
  • Parion Sciences, Inc. (USA)
  • Pfizer, Inc. (USA)
  • Sanofi S.A. (France)

6. GLOBAL MARKET PERSPECTIVE

    • Table 9: World Recent Past, Current and Future Analysis for Ion Channel Modulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 10: World 8-Year Perspective for Ion Channel Modulators by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2015, 2017 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 11: The US Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

2. CANADA

  • Market Analysis
    • Table 12: Canadian Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 13: Japanese Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4. EUROPE

  • Market Analysis
    • Table 14: European Recent Past, Current and Future Analysis for Ion Channel Modulators by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 15: European 8-Year Perspective for Ion Channel Modulators by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2017 & 2022 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • Sanofi S.A. - A Key Player
  • B. Market Analytics
    • Table 16: French Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Bayer HealthCare Pharmaceuticals - A Key German Player in the Ion Channel Modulator Market
  • B. Market Analytics
    • Table 17: German Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 18: Italian Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 19: The UK Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 20: Spanish Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 21: Russian Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Key Players
  • B. Market Analytics
    • Table 22: Rest of Europe Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 23: Asia-Pacific Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 24: Rest of World Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top